Cleararc Capital Inc. Lowers Stake in Agilent Technologies, Inc. (A)

Cleararc Capital Inc. reduced its stake in Agilent Technologies, Inc. (NYSE:A) by 0.1% during the first quarter, according to its most recent filing with the SEC. The firm owned 7,299 shares of the medical research company’s stock after selling 8 shares during the period. Cleararc Capital Inc.’s holdings in Agilent Technologies were worth $386,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the company. Cribstone Capital Management LLC boosted its stake in shares of Agilent Technologies by 2.3% in the first quarter. Cribstone Capital Management LLC now owns 2,359 shares of the medical research company’s stock valued at $125,000 after buying an additional 54 shares during the last quarter. Trust Co. of Vermont boosted its stake in shares of Agilent Technologies by 8.1% in the first quarter. Trust Co. of Vermont now owns 2,743 shares of the medical research company’s stock valued at $145,000 after buying an additional 205 shares during the last quarter. CENTRAL TRUST Co boosted its stake in shares of Agilent Technologies by 15.3% in the first quarter. CENTRAL TRUST Co now owns 2,994 shares of the medical research company’s stock valued at $158,000 after buying an additional 398 shares during the last quarter. Fred Alger Management Inc. bought a new stake in shares of Agilent Technologies during the fourth quarter valued at $182,000. Finally, Penserra Capital Management LLC boosted its stake in shares of Agilent Technologies by 9.5% in the first quarter. Penserra Capital Management LLC now owns 3,496 shares of the medical research company’s stock valued at $184,000 after buying an additional 304 shares during the last quarter.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Shares of Agilent Technologies, Inc. (A) traded down 0.041% during trading on Tuesday, reaching $60.525. 780,663 shares of the company were exchanged. Agilent Technologies, Inc. has a 1-year low of $41.98 and a 1-year high of $61.15. The stock has a market capitalization of $19.45 billion, a P/E ratio of 34.022 and a beta of 1.25. The firm has a 50-day moving average price of $58.19 and a 200-day moving average price of $52.18.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, May 22nd. The medical research company reported $0.58 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.48 by $0.10. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. The company had revenue of $1.10 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter last year, the company posted $0.44 EPS. The firm’s revenue was up 8.1% compared to the same quarter last year. Equities research analysts predict that Agilent Technologies, Inc. will post $2.23 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 26th. Stockholders of record on Monday, July 3rd will be given a dividend of $0.132 per share. The ex-dividend date is Thursday, June 29th. This represents a $0.53 annualized dividend and a dividend yield of 0.87%. Agilent Technologies’s dividend payout ratio (DPR) is currently 29.78%.

ILLEGAL ACTIVITY WARNING: “Cleararc Capital Inc. Lowers Stake in Agilent Technologies, Inc. (A)” was originally posted by Stock Observer and is owned by of Stock Observer. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://www.thestockobserver.com/2017/06/20/cleararc-capital-inc-lowers-stake-in-agilent-technologies-inc-a.html.

Several brokerages have issued reports on A. BidaskClub lowered Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Morgan Stanley boosted their target price on Agilent Technologies from $65.00 to $70.00 and gave the company an “overweight” rating in a research report on Wednesday, May 24th. BTIG Research boosted their target price on Agilent Technologies from $57.00 to $65.00 and gave the company a “buy” rating in a research report on Wednesday, May 24th. Robert W. Baird boosted their target price on Agilent Technologies from $57.00 to $62.00 and gave the company an “outperform” rating in a research report on Wednesday, May 24th. Finally, Jefferies Group LLC boosted their target price on Agilent Technologies from $59.00 to $66.00 and gave the company a “buy” rating in a research report on Tuesday, May 23rd. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $59.31.

In other news, CEO Michael R. Mcmullen sold 50,000 shares of Agilent Technologies stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $59.86, for a total transaction of $2,993,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Didier Hirsch sold 5,710 shares of Agilent Technologies stock in a transaction on Thursday, June 1st. The stock was sold at an average price of $60.60, for a total transaction of $346,026.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 144,101 shares of company stock valued at $8,410,449.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply